Will NIH Return to Three-Strikes?

The National Institutes of Health is reconsidering a rule that limited the numbers of submissions for a given grant applicants to two, due to popular demand for the three-strike policy.

Written byEdyta Zielinska
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

William H. Natcher Builder, on the NIH campus in Bethesda, MDWikimedia Commons, Sage RossIn 2009 the National Institutes of Health (NIH), implemented a new rule, reducing the number of times applicants could apply for a grant with the same proposal from three to two. The agency had found that the additional submissions were creating a bottleneck that delayed the review of first-time submissions. According to a Nature blog, the NIH will now consider repealing that rule, and returning to the former three-strikes policy.

After the two strikes rule was implemented researchers “complained of it nearly incessantly to the NIH Office of Extramural Research,” Nature reported. In 2011, cancer biologist Robert Benezra from Memorial Sloan-Kettering Cancer Center sent a petition with more than 2,300 signatures to the NIH, asking the agency to return to three strikes. The reason, the researchers argued, is that in a tight funding environment, the decision of one grant reviewer can banish a proposal from success. By resubmitting, scientists get a second shot, often with a whole new review committee.

“If a reviewer doesn’t like how you use semicolons, or is having a bad hair day before the coffee kicks in , or was once threatened by one of your papers, you can fall from ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery